Edition:
India

People: Carl Zeiss Meditec AG (AFXG.DE)

AFXG.DE on Xetra

97.90EUR
18 Jul 2019
Change (% chg)

€0.60 (+0.62%)
Prev Close
€97.30
Open
€97.05
Day's High
€98.50
Day's Low
€96.35
Volume
138,280
Avg. Vol
195,409
52-wk High
€98.60
52-wk Low
€60.25

Monz, Ludwin 

Dr. Ludwin Monz has been Chairman of the Management Board and Chief Executive Officer of Carl Zeiss Meditec AG since March 4, 2010. He served as Member of the Management Board at the Company as of October 8, 2007. With effect from October 1, 2008, Dr. Monz has been appointed new Head of the SBU Ophthalmic Systems. He was previously responsible for the SBU Neuro/ENT Surgery. He is Member of the Management Board of Carl Zeiss AG. Dr. Monz holds a Doctorate in Physics from Johannes Gutenberg-Universitaet Mainz and received a Master of Business Administration degree from Henley Management College, United Kingdom. He has been working for Carl Zeiss since 1994 and has held a number of management positions within the Medical Technology division of Carl Zeiss since 2000, most recently as Chairman of the Management Board of Carl Zeiss Surgical.

Basic Compensation

Total Annual Compensation, EUR 703,300
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR 264,600
All Other, EUR 16,300
Fiscal Year Total, EUR 984,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --